A differentiated effector T cell repertoire defines a functionally high-risk group of smoldering myeloma patients - Poll - MDSpire

A differentiated effector T cell repertoire defines a functionally high-risk group of smoldering myeloma patients

  • By

  • Ross S. Firestone

  • Anish K. Simhal

  • Theresia Akhlaghi

  • Jung Hun Oh

  • Devin McAvoy

  • Kylee H. Maclachlan

  • Juan-Jose Garces

  • Sham Mailankody

  • Hani Hassoun

  • Urvi A. Shah

  • Neha Korde

  • Carlyn R. Tan

  • Sridevi Rajeeve

  • Hamza Hashmi

  • Alexander M. Lesokhin

  • Kinga Hosszu

  • Francesco Maura

  • Joseph O. Deasy

  • Saad Z. Usmani

  • Malin Hultcrantz

  • May 1, 2026

  • 0 min

Share

Original Source(s)

A differentiated effector T cell repertoire defines a functionally high-risk group of smoldering myeloma patients

  • by Ross S. Firestone, Anish K. Simhal, Theresia Akhlaghi, Jung Hun Oh, Devin McAvoy, Kylee H. Maclachlan, Juan-Jose Garces, Sham Mailankody, Hani Hassoun, Urvi A. Shah, Neha Korde, Carlyn R. Tan, Sridevi Rajeeve, Hamza Hashmi, Alexander M. Lesokhin, Kinga Hosszu, Francesco Maura, Joseph O. Deasy, Saad Z. Usmani, Malin Hultcrantz

  • May 1, 2026

Related Content

Outcomes of critically ill pediatric patients after haploidentical stem cell transplantation

Treatment evolution and survival impact of consolidation therapies in mantle cell lymphoma: insights from an Asia-Pacific real-world registry

Prospective phase II study of frontline Helicobacter pylori eradication therapy for early-stage extragastric mucosa-associated lymphoid tissue lymphoma